C1QBP and systemic lupus erythematosus: Further investigation into the roles of C1q and gC1qR on the surface of CD4+ T cells could not only provide new insight into the roles of these molecules in the immune activation leading to SLE, but may also help in the design of new therapeutic treatment options in a manner similar to treatments of angioedema with recombinant C1.